Therefore, to our knowledge, this is the first report to show both an increase in the number of methylated RUNX3 copies with lymph-vascular invasion and tumor size in early gastric cancer and a significant association between an increase in methylated RUNX3 copies and massive submucosal (sm2) invasion. The gene discussed is RUNX3; the disease is neoplasm.